AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32459016 — intervention group
Group type: COMPARATOR
Intervention: Control group (plain permeation cream)
Number of subjects: 30
Study 35179756 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatic Acupuncture (SA)
Number of subjects: 120
Study 35179756 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular Acupuncture (AA)
Number of subjects: 120
Study 35179756 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological Treatment (PT)
Number of subjects: 120
Study 35691487 — intervention group
Group type: EXPERIMENTAL
Intervention: Active support from trusted community health workers
Number of subjects: 400
Study 35691487 — intervention group
Group type: COMPARATOR
Intervention: Passive support (no active support)
Number of subjects: 400
Study 32011825 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 32
Study 32011825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 35314634 — intervention group
Group type: EXPERIMENTAL
Intervention: Belinostat (500-750 mg/m2 1×/day × 5 days every three weeks)
Number of subjects: 26
Study 35314634 — intervention group
Group type: COMPARATOR
Intervention: Control (standard-of-care therapy including temozolomide and radiation therapy)
Number of subjects: 26
Study 34596671 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate IBBR with Acellular Dermal Matrix (ADM)
Number of subjects: 135
Study 34596671 — intervention group
Group type: COMPARATOR
Intervention: IBBR without Acellular Dermal Matrix (Control)
Number of subjects: 135
Study 32503004 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week aerobic and resistance exercise training (n = 23)
Number of subjects: 45
Study 32503004 — intervention group
Group type: COMPARATOR
Intervention: No exercise group (control, n = 22)
Number of subjects: 45
Study 35834228 — intervention group
Group type: EXPERIMENTAL
Intervention: Mismatch Repair Deficiency (MMRD)
Number of subjects: 0
Study 35834228 — intervention group
Group type: COMPARATOR
Intervention: Mismatch Repair Proficiency (MMRP)
Number of subjects: 0
Study 35351367 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-acupressure (16 sessions, 2 days a week, 27 min each session)
Number of subjects: 62
Study 35351367 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-acupressure
Number of subjects: 62
Study 35351367 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study 32032233 — intervention group
Group type: EXPERIMENTAL
Intervention: VMAX (squat with intention to move the bar as fast as possible)
Number of subjects: 14
Study 32032233 — intervention group
Group type: COMPARATOR
Intervention: CON (controlled half-squat at self-selected normal tempo)
Number of subjects: 14
Study 33108690 — intervention group
Group type: EXPERIMENTAL
Intervention: Fairplayer.Sport intervention
Number of subjects: 145
Study 33108690 — intervention group
Group type: COMPARATOR
Intervention: Waiting-control group
Number of subjects: 145
Study 33267729 — intervention group
Group type: COMPARATOR
Intervention: NORMAL group (unprocessed speech signal in contralateral ear)
Number of subjects: 60
Study 33267729 — intervention group
Group type: EXPERIMENTAL
Intervention: LOWPASS group (low-pass filtered speech signal in contralateral ear)
Number of subjects: 60
Study 33267729 — intervention group
Group type: EXPERIMENTAL
Intervention: NOTHING group (no sound in contralateral ear)
Number of subjects: 60
Study 32474427 — intervention group
Group type: EXPERIMENTAL
Intervention: LARS patient‐centred programme (LPCP) consisting of an informational booklet, patient diaries, and nurse support
Number of subjects: 0
Study 32474427 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34144246 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVE! + UP
Number of subjects: 164
Study 34144246 — intervention group
Group type: COMPARATOR
Intervention: MOVE!
Number of subjects: 164
Study 32620717 — intervention group
Group type: COMPARATOR
Intervention: Mouthwash containing 0.12% chlorhexidine‐gluconate (Group 2)
Number of subjects: 40
Study 32620717 — intervention group
Group type: EXPERIMENTAL
Intervention: No mouthwash (Group 1)
Number of subjects: 40
Study 32620717 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthwash containing essential-oils (Group 3)
Number of subjects: 40
Study 32620717 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthwash containing 7.5% povidone-iodine (Group 4)
Number of subjects: 40
Study 36002106 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-unit UCB transplantation
Number of subjects: 278
Study 36002106 — intervention group
Group type: COMPARATOR
Intervention: Real-world group (RW) with single-unit UCB transplantation
Number of subjects: 278
Study 36002106 — intervention group
Group type: COMPARATOR
Intervention: Real-world group (RW)
Number of subjects: 278
Study 34571090 — intervention group
Group type: EXPERIMENTAL
Intervention: WBRT + boost (arm B)
Number of subjects: 2004
Study 34571090 — intervention group
Group type: COMPARATOR
Intervention: WBRT (arm A)
Number of subjects: 2004
Study 32927741 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional education and a low to moderate multi-component exercise program
Number of subjects: 60
Study 32927741 — intervention group
Group type: COMPARATOR
Intervention: Control arm (not specified)
Number of subjects: 60
Study 36183129 — intervention group
Group type: EXPERIMENTAL
Intervention: Your Care Needs You (YCNY) intervention
Number of subjects: 161
Study 36183129 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 161
Study 34715827 — intervention group
Group type: EXPERIMENTAL
Intervention: Antifungal therapy after surgery
Number of subjects: 0
Study 34715827 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antifungal therapy)
Number of subjects: 0
Study 34715827 — intervention group
Group type: EXPERIMENTAL
Intervention: Antifungal therapy
Number of subjects: 0
Study 35164485 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-free anesthesia (OFA)
Number of subjects: 78
Study 34004271 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytobiotic blend (FTB)
Number of subjects: 56
Study 34004271 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic antibiotic (ATB)
Number of subjects: 56
Study 34004271 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 56
Study 32447657 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-PD-1/PD-L1 monoclonal antibodies
Number of subjects: 0
Study 32447657 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination immunotherapy
Number of subjects: 0
Study 32447657 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-PD-1/PD-L1
Number of subjects: 0
Study 36372870 — intervention group
Group type: EXPERIMENTAL
Intervention: Game-based real-time feedback intervention
Number of subjects: 13
Study 32693660 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) along with pharmacotherapy (PT)
Number of subjects: 150
Study 32693660 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy (PT) only
Number of subjects: 150
Study 35270698 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular spaghetti No 7
Number of subjects: 14
Study 35270698 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole wheat spaghetti No 7
Number of subjects: 14
Study 35270698 — intervention group
Group type: EXPERIMENTAL
Intervention: High soluble fiber–low carbohydrates spaghetti No 7
Number of subjects: 14
Study 35270698 — intervention group
Group type: COMPARATOR
Intervention: Glucose reference
Number of subjects: 14
Study 35270698 — intervention group
Group type: COMPARATOR
Intervention: White bread
Number of subjects: 14
Study 35270698 — intervention group
Group type: EXPERIMENTAL
Intervention: All spaghetti types
Number of subjects: 14
Study 33059638 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind in Labor (MIL)
Number of subjects: 30
Study 33059638 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 30
Study 35967116 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent-start peritoneal dialysis (PD)
Number of subjects: 207
Study 35967116 — intervention group
Group type: COMPARATOR
Intervention: Urgent-start temporary hemodialysis (HD)
Number of subjects: 207
Study 32434001 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepregnancy platelet factor 4 (third tertile vs first tertile)
Number of subjects: 1185
Study 32434001 — intervention group
Group type: COMPARATOR
Intervention: Prepregnancy platelet factor 4 (third tertile vs first tertile) in placebo group
Number of subjects: 1185
Study 32434001 — intervention group
Group type: COMPARATOR
Intervention: Prepregnancy platelet factor 4 (third tertile vs first tertile) in aspirin group
Number of subjects: 1185
Study 33539149 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative feedback condition
Number of subjects: 126
Study 33539149 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive feedback condition
Number of subjects: 126
Study 33539149 — intervention group
Group type: EXPERIMENTAL
Intervention: No feedback condition
Number of subjects: 126
Study 32860399 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D-3 per day
Number of subjects: 32
Study 32860399 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 mg CLA per day
Number of subjects: 32
Study 32860399 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D-3 and 4000 mg CLA per day
Number of subjects: 32
Study 32860399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 36017026 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathe‐Link breathing trainers with rehabilitation training for 12 weeks
Number of subjects: 60
Study 36017026 — intervention group
Group type: COMPARATOR
Intervention: Routine breathing training (Control group)
Number of subjects: 60
Study 32345653 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 51
Study 32345653 — intervention group
Group type: COMPARATOR
Intervention: Gluten-containing diet (GCD)
Number of subjects: 51
Study 35593607 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg) + Thiocolchicoside (8 mg)
Number of subjects: 35
Study 35593607 — intervention group
Group type: COMPARATOR
Intervention: Nimesulide (100 mg)
Number of subjects: 35
Study 33048589 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) counts/minutes
Number of subjects: 97
Study 33048589 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sleep time
Number of subjects: 97
Study 33048589 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 97
Study 34498818 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 g/kg of carbohydrate (CHO)
Number of subjects: 9
Study 34498818 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 g/kg of carbohydrate with 6 mg/kg of caffeine (CAF+CHO)
Number of subjects: 9
Study 34498818 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 9
Study 36389109 — intervention group
Group type: COMPARATOR
Intervention: Propofol-Remifentanil (PR)
Number of subjects: 200
Study 36389109 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-Dexmedetomidine (PD)
Number of subjects: 200
Study 32234083 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐based personalised nutrition (PN) advice
Number of subjects: 1607
Study 32234083 — intervention group
Group type: COMPARATOR
Intervention: Conventional dietary advice (control)
Number of subjects: 1607
Study 33371769 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-severe hearing difficulties
Number of subjects: 1037
Study 33371769 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing devices
Number of subjects: 1037
Study 35229960 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg nicotine delivered over 1 min
Number of subjects: 24
Study 35229960 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg nicotine delivered over 2.5 min
Number of subjects: 24
Study 35229960 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg nicotine delivered over 5 min
Number of subjects: 24
Study 35229960 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg nicotine delivered over 10 min
Number of subjects: 24
Study 35229960 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 24
Study 35229960 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg nicotine/min
Number of subjects: 24
Study 35229960 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg nicotine/min
Number of subjects: 24
Study 35229960 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg nicotine/min
Number of subjects: 24
Study 35229960 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg nicotine/min
Number of subjects: 24
Study 35936870 — intervention group
Group type: EXPERIMENTAL
Intervention: 360-degree nature videos via head-mounted display (HMD)
Number of subjects: 36
Study 35936870 — intervention group
Group type: EXPERIMENTAL
Intervention: 360-degree nature videos via PC screen
Number of subjects: 36
Study 35936870 — intervention group
Group type: COMPARATOR
Intervention: Control condition (listening to natural sounds without video)
Number of subjects: 36
Study 34672468 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient exercise training (ET), 30 min/d, 5 d/week, for 12 weeks
Number of subjects: 36
Study 34672468 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient exercise training (ET), 30 min/d, 5 d/week, for 12 weeks
Number of subjects: 36
Study 34672468 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional cardiac rehabilitation without ET), n=12
Number of subjects: 36
Study 36326156 — intervention group
Group type: EXPERIMENTAL
Intervention: Packs of 20 cigarettes
Number of subjects: 236
Study 36326156 — intervention group
Group type: COMPARATOR
Intervention: Packs of 25 cigarettes
Number of subjects: 236
Study 33531268 — intervention group
Group type: EXPERIMENTAL
Intervention: Coban™ 2 (3M)
Number of subjects: 49
Study 33531268 — intervention group
Group type: COMPARATOR
Intervention: Standard care, non-compression bandaging
Number of subjects: 49
Study 32447582 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapeseed pod meal (RPM) at levels of 0, 20, 40, 60, 80, and 100% of dietary substrate
Number of subjects: 12
Study 32447582 — intervention group
Group type: EXPERIMENTAL
Intervention: Roughage to concentrate (R:C) ratios of 60:40 and 40:60
Number of subjects: 12
Study 32447582 — intervention group
Group type: EXPERIMENTAL
Intervention: Roughage to concentrate (R:C) ratios and levels of RPM
Number of subjects: 12
Study 32447582 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing levels of RPM
Number of subjects: 12
Study 35785593 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily teriparatide
Number of subjects: 0
Study 35785593 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly high-dose teriparatide
Number of subjects: 0
Study 35785593 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonate
Number of subjects: 0
Study 35027397 — intervention group
Group type: EXPERIMENTAL
Intervention: Vector vaccine ChAdOx1 nCoV-19 (Oxford-AstraZeneca)
Number of subjects: 60
Study 35027397 — intervention group
Group type: COMPARATOR
Intervention: mRNA vaccine (homologous)
Number of subjects: 60
Study 35027397 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall seroconversion
Number of subjects: 60
Study 35027397 — intervention group
Group type: EXPERIMENTAL
Intervention: Vector vaccine
Number of subjects: 60
Study 35027397 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA vaccine
Number of subjects: 60
Study 35027397 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall newly induced humoral and/or cellular responses
Number of subjects: 60
Study 35027397 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without detectable peripheral B cells
Number of subjects: 60
Study 35027397 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with detectable peripheral B cells
Number of subjects: 60
Study 32991493 — intervention group
Group type: EXPERIMENTAL
Intervention: Meyers and McKeever classification
Number of subjects: 40
Study 32991493 — intervention group
Group type: EXPERIMENTAL
Intervention: Various measurements of tibial spine fractures
Number of subjects: 40
Study 32991493 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Type III and IV classification
Number of subjects: 40
Study 32991493 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction versus closed reduction
Number of subjects: 40
Study 32866440 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab 162 mg subcutaneously weekly for 48 weeks
Number of subjects: 210
Study 32866440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 32866440 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 210
Study 34250845 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality status assessment using ICD‐11 system
Number of subjects: 200
Study 34250845 — intervention group
Group type: EXPERIMENTAL
Intervention: DSM‐III diagnosed patients
Number of subjects: 200
Study 34582462 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial (azithromycin and nitazoxanide)
Number of subjects: 1084
Study 34582462 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide
Number of subjects: 1084
Study 34582462 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for both interventions)
Number of subjects: 1084
Study 616039429 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye movement training followed by fixation training
Number of subjects: 4
Study 616039429 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixation training followed by eye movement training
Number of subjects: 4
Study 616039429 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 4
Study 35732089 — intervention group
Group type: EXPERIMENTAL
Intervention: Nap
Number of subjects: 40
Study 35732089 — intervention group
Group type: COMPARATOR
Intervention: Wake
Number of subjects: 40
Study 32978539 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised text messaging (24 messages per week with tailored preventive advice)
Number of subjects: 171
Study 32978539 — intervention group
Group type: COMPARATOR
Intervention: Non-personalised text messaging (24 messages per week without tailored advice)
Number of subjects: 171
Study 32978539 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised text messaging
Number of subjects: 171
Study 33464660 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg CBD
Number of subjects: 78
Study 33464660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 33464660 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD
Number of subjects: 78
Study 33044203 — intervention group
Group type: EXPERIMENTAL
Intervention: Insole on less affected side during treadmill walking training (ILTW)
Number of subjects: 0
Study 33044203 — intervention group
Group type: COMPARATOR
Intervention: Normal treadmill training (NTW)
Number of subjects: 0
Study 34962151 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 0
Study 34962151 — intervention group
Group type: COMPARATOR
Intervention: Self-Monitoring with Blood Glucose Meter (BGM)
Number of subjects: 0
Study 33242924 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic counselling intervention (IMAGINE) with a board‐certified genetic counsellor
Number of subjects: 110
Study 33242924 — intervention group
Group type: COMPARATOR
Intervention: No genetic counselling intervention (control group)
Number of subjects: 110
Study 33242924 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic counselling intervention (IMAGINE)
Number of subjects: 110
Study 35851700 — intervention group
Group type: EXPERIMENTAL
Intervention: IgE-mediated food allergy
Number of subjects: 541
Study 35851700 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-immune-mediated reactions to food additives
Number of subjects: 541
Study 35851700 — intervention group
Group type: COMPARATOR
Intervention: Oral food challenges
Number of subjects: 541
Study 32053942 — intervention group
Group type: EXPERIMENTAL
Intervention: Melon concentrate (SOD B® M)
Number of subjects: 0
Study 35385516 — intervention group
Group type: EXPERIMENTAL
Intervention: Women authors in computer systems research
Number of subjects: 19429
Study 35385516 — intervention group
Group type: COMPARATOR
Intervention: Conference factors (size, prestige, double‐blind reviewing, inclusivity policies)
Number of subjects: 19429
Study 35385516 — intervention group
Group type: COMPARATOR
Intervention: Author research experience
Number of subjects: 19429
Study 35385516 — intervention group
Group type: COMPARATOR
Intervention: Author country and work sector
Number of subjects: 19429
Study 34131726 — intervention group
Group type: EXPERIMENTAL
Intervention: Gavi® (semi-automated closed vitrification system)
Number of subjects: 149
Study 34131726 — intervention group
Group type: COMPARATOR
Intervention: Cryotop® (manual open vitrification system)
Number of subjects: 149
Study 34131726 — intervention group
Group type: EXPERIMENTAL
Intervention: Gavi®
Number of subjects: 149
Study 34131726 — intervention group
Group type: COMPARATOR
Intervention: Cryotop®
Number of subjects: 149
Study 34131726 — intervention group
Group type: EXPERIMENTAL
Intervention: Gavi® and Cryotop®
Number of subjects: 149
Study 32423446 — intervention group
Group type: EXPERIMENTAL
Intervention: Art group (ATP, game-based, and music-based education)
Number of subjects: 200
Study 32423446 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers group (children received ATP and mothers received education by telephone)
Number of subjects: 200
Study 32423446 — intervention group
Group type: COMPARATOR
Intervention: Control group (children received ATP)
Number of subjects: 200
Study 35147767 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer generation drug eluting stents (DES)
Number of subjects: 4953
Study 33860793 — intervention group
Group type: EXPERIMENTAL
Intervention: RCTs with positive results (n=86)
Number of subjects: 238
Study 33860793 — intervention group
Group type: COMPARATOR
Intervention: RCTs with negative results (n=152)
Number of subjects: 238
Study 33860793 — intervention group
Group type: EXPERIMENTAL
Intervention: Published manuscripts
Number of subjects: 238
Study 35843776 — intervention group
Group type: EXPERIMENTAL
Intervention: pembrolizumab + axitinib
Number of subjects: 861
Study 35843776 — intervention group
Group type: COMPARATOR
Intervention: sunitinib
Number of subjects: 861
Study 34394385 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone plus hypertonic saline 5%
Number of subjects: 34
Study 34394385 — intervention group
Group type: COMPARATOR
Intervention: Hypertonic saline 5% alone
Number of subjects: 34